Markets:

Overview

News

Currencies

International

Treasuries

Immuneering Corporation - Class A Common Stock (NQ:IMRX)

5.000 -0.250 (-4.76%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Immuneering Corporation - Class A Common Stock

< Previous 1 2 3 4 5 Next >

Immuneering’s Positive Pancreatic Cancer Trial Data Sparks Bullish Retail Sentiment Even As Profit-Taking Cools Rally ↗

June 17, 2025

The company plans to launch a pivotal trial in 2026 and expects additional clinical data and regulatory feedback by the end of 2025.

Via Stocktwits

These stocks are moving in today's session ↗

June 17, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 16, 2025

Via Benzinga

These stocks are gapping in today's session ↗

June 16, 2025

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Why Is Immuneering Stock Trading Higher On Tuesday? ↗

January 07, 2025

Immuneering reveals promising Phase 2a pancreatic cancer trial updates for IMM-1-104, showcasing efficacy, safety, and future expansion plans.

Via Benzinga

Why is Immuneering (IMRX) Stock Up 24% Today? ↗

August 01, 2024

Up nearly 25% in today's session on a fast track designation for a key pancreatic cancer drug candidate, IMRX stock is coming into focus.

Via InvestorPlace

Maximize Your Trades: Pre-Market Insights And Key Stock Breakdowns ↗

January 13, 2025

Via Talk Markets

Topics ETFs Stocks / Equities

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 07, 2025

Via Benzinga

Mastering Market Chaos: StoryTrading’s Top 5 Stocks You Can’t Ignore ↗

December 20, 2024

The trading landscape is alive with opportunity, shaped by a mix of macroeconomic events and sector-specific moves.

Via Talk Markets

Topics Stocks / Equities

Top Trade Picks Of The Day: Don’t Miss These Market Movers ↗

December 17, 2024

Discover today’s top stock opportunities with our 4-pillar strategy, combining catalysts, sentiment, fundamentals, and technicals to highlight 6 must-watch trades before the market opens.

Via Talk Markets

Topics Stocks / Equities

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday? ↗

December 13, 2024

Morgan Stanley downgrades Amicus Therapeutics, Immunocore, and Immuneering, citing pricing challenges, pipeline updates, and cautious growth outlooks.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 15, 2024

Via Benzinga

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank? ↗

October 02, 2024

A look at the 20 most searched tickers on Benzinga Pro, which includes many familiar names and some penny stocks that may be less familiar.

Via Benzinga

Why Is Nanocap Immuneering Stock Trading Higher On Friday? ↗

September 13, 2024

Immuneering reported promising initial response data from its Phase 2a trial for IMM-1-104 combined with modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer, showing a 40% response rate...

Via Benzinga

Nasdaq Surges 1%; Meta Posts Upbeat Earnings ↗

August 01, 2024

Via Benzinga

Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗

August 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 11, 2024

Via Benzinga

IMRX Stock Earnings: Immuneering Misses EPS for Q1 2024 ↗

May 07, 2024

IMRX stock results show that Immuneering missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 18, 2024

Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 18, 2024

Via Benzinga

Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data ↗

March 15, 2024

Immuneering shares dip as analysts express concern over IMM-1-104 trial results. Needham downgrades, citing efficacy issues despite promising mechanism of action. Optimism remains for earlier-stage...

Via Benzinga

Dow Falls Over 200 Points; Adobe Shares Plunge ↗

March 15, 2024

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 200 points on Friday. The Dow traded down 0.55% to 38,692.43 while the NASDAQ fell 0.90% to 15,982.65. The S&P...

Via Benzinga

Topics Stocks

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 15, 2024

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 15, 2024

Via Benzinga

Crude Oil Edges Lower; US Consumer Sentiment Falls In March ↗

March 15, 2024

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points on Friday. The Dow traded down 0.37% to 38,761.74 while the NASDAQ fell 0.95% to 15,974.83. The S&P 500...

Via Benzinga

Topics Stocks

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 14, 2024

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 14, 2024

Via Benzinga

What's Going On With Cancer-Focused Immuneering Stock On Thursday? ↗

March 14, 2024

Unlock the latest Phase 1 trial results for IMM-1-104 by Immuneering. Discover how 320mg and 240mg doses inhibit tumor progression and evaluate safety profiles.

Via Benzinga

US Stocks Higher; Producer Prices Rise 0.6% In February ↗

March 14, 2024

U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.11% to 39,084.58 while the NASDAQ rose 0.30% to 16,226.13. The S&P...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Immuneering Corporation - Class A Common Stock (NQ:IMRX)

Headline News about Immuneering Corporation - Class A Common Stock

Starting at $3.75/week.

Subscribe Today